UN, Gamida Cell Ltd, hematologic malignitates, Omidubicel
Omidubicel ab USFDA approbatur reducere tempus ad recuperationem neutrophilem et infectionem patientibus malignitatibus hematologicis
Maii 2023: Omidubicel-onlv (Omisirge, Gamida Cell Ltd.) approbata est ab Administratione Cibus et medicamentis ad usum in aegris adultis et pediatricibus (XII annis et supra) malignis hematologicis qui horarium recipiunt.
Beta Thalassaemia, UN, XIX, Covid, India, Thalassaemia
Beta-XIX COVID Thalassaemia considerationem et
Iulii 2021: Beta-thalassemia hereditas est condicio mutationum in genere implicata in productione componentis haemoglobinae, dapibus quae oxygenium in totum corpus transportat. Hae mutationes aut prohibent ..
UN, Medullae ossium PLANTO, Derivantur cellula capillum traducere
Medullae ossium PLANTO in India
Bone marrow transplant in India Bone marrow stem cell transplants in India are performed by some of the leading cancer centres. To date, more than 10,000 successful bone marrow stem cell transplants have been performed in India. ..